Robert Coffin
Oprichter bij REPLIMUNE GROUP, INC.
Vermogen: 11 M $ op 30-04-2024
Actieve functies van Robert Coffin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REPLIMUNE GROUP, INC. | Directeur/Bestuurslid | 01-03-2015 | - |
| Hoofd Techniek/Wetenschap/O&O | - | - | |
| Oprichter | 01-03-2015 | - | |
| Algemeen Directeur | 01-03-2015 | 09-01-2020 | |
| President | 01-03-2015 | 01-04-2024 |
Loopbaan van Robert Coffin
Eerdere bekende functies van Robert Coffin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Directeur/Bestuurslid | 01-01-1999 | 24-01-2013 |
| Hoofd Techniek/Wetenschap/O&O | 01-01-1999 | 24-01-2013 | |
| Oprichter | 15-10-2009 | 24-01-2013 | |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2011 | 01-01-2013 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 01-01-1999 | 04-03-2011 |
| Hoofd Techniek/Wetenschap/O&O | 01-01-1999 | 04-03-2011 | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Directeur/Bestuurslid | 01-01-1999 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-1999 | - | |
| Oprichter | 01-01-1999 | - |
Opleiding van Robert Coffin
| Imperial College London | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
Sectoraal
| Health Technology | 5 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
- Beurs
- Insiders
- Robert Coffin
- Ervaring
